Home Newsfeeds EF Hutton Reiterates Buy on Acer Therapeutics, Maintains $7 Price Target

EF Hutton Reiterates Buy on Acer Therapeutics, Maintains $7 Price Target

EF Hutton analyst Constantine Davides reiterates Acer Therapeutics (NASDAQ:ACER) with a Buy and maintains $7 price target.

byBenzinga Newsdesk

March 20, 2023

1 minute read

EF Hutton analyst Constantine Davides reiterates Acer Therapeutics (NASDAQ:ACER) with a Buy and maintains $7 price target.

Assurant Partners With CNH Industrial Capital, The Captive Finance Company Of CNH Industrial, To Provide Equipment Protection And Insurance Products Through Their Dealer Network

By Benzinga Newsdesk

April 20, 8:53 AM

This partnership delivers best-in-class protection products through Assurant's growing commercial equipment business.Assurant, Inc. (NYSE:AIZ), a leading global business services company that supports, protects, and

AIZ

Analyst Ratings

Expert Ratings for Costco Wholesale

By Benzinga Insights

November 7, 9:52 AM

Over the past 3 months, 6 analysts have published their opinion on Costco Wholesale (NASDAQ:COST) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

COST